Shoulder Innovations, Inc. (SI)

NYSE: SI · Real-Time Price · USD
15.00
+2.26 (17.74%)
Sep 11, 2025, 4:00 PM EDT - Market closed
17.74%
Market Cap305.40M
Revenue (ttm)37.32M
Net Income (ttm)-31.71M
Shares Out 20.36M
EPS (ttm)-363.42
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume212,041
Open13.08
Previous Close12.74
Day's Range13.00 - 15.29
52-Week Range11.75 - 17.94
Betan/a
AnalystsStrong Buy
Price Target19.60 (+30.67%)
Earnings DateSep 9, 2025

About SI

Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States. It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion. The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan. [Read more]

Sector Healthcare
IPO Date Jul 31, 2025
Employees 56
Stock Exchange NYSE
Ticker Symbol SI
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

Analyst Summary

According to 5 analysts, the average rating for SI stock is "Strong Buy." The 12-month stock price target is $19.6, which is an increase of 30.67% from the latest price.

Price Target
$19.6
(30.67% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Shoulder surgery-focused medtech Shoulder Innovations files for a $100 million IPO

Shoulder Innovations, which offers advanced implant systems for shoulder arthroplasty, filed on Monday with the SEC to raise up to $100 million in an initial public offering.

2 months ago - Renaissance Capital

Shoulder Innovations IPO Registration Document (S-1)

Shoulder Innovations has filed to go public with an IPO on the New York Stock Exchange (NYSE).

2 months ago - SEC